- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/173 - Purine radicals with 2-deoxyribosyl as the saccharide radical
Patent holdings for IPC class C07H 19/173
Total number of patents in this class: 260
10-year publication summary
|
19
|
17
|
11
|
16
|
18
|
14
|
16
|
10
|
14
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 1957 |
15 |
| Agilent Technologies, Inc. | 2679 |
10 |
| Nucana plc | 84 |
8 |
| Merck Sharp & Dohme LLC | 3752 |
8 |
| Alnylam Pharmaceuticals, Inc. | 1137 |
7 |
| Illumina Cambridge Limited | 677 |
7 |
| ViiV Healthcare Company | 157 |
6 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 283 |
5 |
| Alios BioPharma, Inc. | 67 |
5 |
| Janssen Biopharma, Inc. | 49 |
5 |
| Ajinomoto Co., Inc. | 2319 |
4 |
| CARIS Science, Inc. | 67 |
4 |
| The Scripps Research Institute | 1352 |
4 |
| Merck Sharp & Dohme Corp. | 2217 |
3 |
| Janssen Pharmaceuticals, Inc. | 411 |
3 |
| Massachusetts Institute of Technology | 9921 |
3 |
| Idenix Pharmaceuticals LLC | 64 |
3 |
| Ionis Pharmaceuticals, Inc. | 844 |
3 |
| Isis Pharmaceuticals, Inc. | 227 |
3 |
| The Regents of the University of Colorado, a body corporate | 2534 |
3 |
| Other owners | 151 |